Home » Topics » Regulatory » Patents

Patents
RSS

RAPT Therapeutics patents USP7 inhibitors

Nov. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical describes HBV antivirals

Nov. 4, 2021

Chinese researchers present new glucose-lowering agents

Nov. 4, 2021

Disarm Therapeutics discloses SARM1 inhibitors

Nov. 4, 2021

Keaise Medicine patents TRXR inhibitors

Nov. 4, 2021

U.S. researchers patent new meayamycin derivatives

Nov. 3, 2021

GB005 synthesizes BTK inhibitors

Nov. 3, 2021

UCB identifies new IL-17 modulators

Nov. 3, 2021

Foghorn Therapeutics discloses new PROTACs

Nov. 3, 2021

Sanofi patents new YAP1/TEAD interaction inhibitors

Nov. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...